According to Kratos Defense & Security Solutions, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 25 08:19 PM, company EVP & CFO, Lund Deanna H disclosed selling 7,800 shares at a cost of $20.39. At the time of this transaction (Nov 23), this trade was […]
According to Kratos Defense & Security Solutions, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 25 08:14 PM, company SVP, Corp. Dev. & Gov. Affairs, Goodwin Benjamin M. disclosed selling 600 shares at a cost of $21.32. At the time of this transaction (Nov 24), […]
According to Cyanotech Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 25 08:09 PM, company Director, Menzel Walter Bennett disclosed selling 41,845 shares at a cost of $2.58. At the time of this transaction (Nov 23), this trade was worth $107,960 in total. As of […]
According to Kratos Defense & Security Solutions, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 25 08:06 PM, company President & CEO, Demarco Eric M disclosed selling 15,000 shares at a cost of $20.58. At the time of this transaction (Nov 23), this trade was […]
According to Kratos Defense & Security Solutions, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 25 08:06 PM, company President & CEO, Demarco Eric M disclosed selling 5,000 shares at a cost of $20.58. At the time of this transaction (Nov 23), this trade was […]
According to Intellia Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 25 08:02 PM, company President and CEO, Leonard John M disclosed selling 50,000 shares at a cost of $36.00. At the time of this transaction (Nov 25), this trade was worth $1,800,000 in […]
According to Gw Pharmaceuticals Plc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 25 08:00 PM, company Chief Medical Officer, Knappertz Volker disclosed selling 12,000 shares at a cost of $10.50. At the time of this transaction (Nov 24), this trade was worth $126,000 in total. […]
According to Asgn Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 25 07:59 PM, company Director, Sheridan Edwin A. disclosed selling 43,159 shares at a cost of $82.09. At the time of this transaction (Nov 24), this trade was worth $3,543,039 in total. As of […]
According to Asgn Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 25 07:56 PM, company Director, Callaghan Brian J. disclosed selling 53,190 shares at a cost of $82.29. At the time of this transaction (Nov 24), this trade was worth $4,377,133 in total. As of […]
According to Asgn Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 25 07:56 PM, company Director, Callaghan Brian J. disclosed selling 21,810 shares at a cost of $82.51. At the time of this transaction (Nov 23), this trade was worth $1,799,467 in total. As of […]
PayPal Withdrawing Support For Kindle Fire, BlackBerry And Windows Phone
Revival Of Nashville Discussed
Brawl Erupts After Jose Bautista Downed By Rougned Odor Punch
VR Tour Offered Three Decades After Chernobyl Disaster
Kyle Busch Sweeps NASCAR Events At Martinsville
Halle Berry Enters The Social Media World
